Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631 1672 1682 1685
This examiner grants 27% of resolved cases
Kaitlyn L. Minchella examines in Art Unit 1631 and has 161 resolved cases. Her allowance rate is 26.7 percent, which is on the lower end for Tech Center 1600. This figure reflects a rigorous examination environment for the applications assigned to her.
The interview lift of 21.8 percent suggests that while interviews help, the overall probability of allowance remains relatively low compared to the 26.7 percent baseline. However, the 21.8 percent lift still represents a valuable opportunity for applicants to clarify their claims and address examiner concerns.
The median days to allowance is 1594. This long timeframe for 161 resolved cases indicates a slow and thorough examination process. The 1594 day median is a significant factor for practitioners to consider when managing client expectations for pendency.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18450468 | SYSTEMS AND METHODS FOR IDENTIFYING SEQUENCE VARIATION ASSOCIATED WITH GENETIC DISEASES | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
| 17762097 | Systems and Methods for the Efficient Identification and Extraction of Sequence Paths in Genome Graphs | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 17745399 | NANOPORE SENSOR FOR ENZYME-MEDIATED PROTEIN TRANSLOCATION | Final Rejection | The Regents of the University of California |
| 17204892 | CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER | Final Rejection | The Johns Hopkins University |
| 18133798 | SYSTEMS AND METHODS FOR GENERATING A GENOTYPIC CAUSAL MODEL OF A DISEASE STATE | Non-Final OA | KPN INNOVATIONS, LLC. |
| 17759734 | METHOD AND COMPOSITION FOR MICROBIOME BASED AMELIORATION OF SKIN ASSOCIATED AUTOIMMUNE INFLAMMATORY DISEASES | Non-Final OA | Tata Consultancy Services Limited |
| 18555972 | ANALYSIS METHOD OF BASE SEQUENCE AND GENE ANALYZER | Non-Final OA | Hitachi High-Tech Corporation |
| 17773031 | METHOD FOR IDENTIFYING TRANSPLANT DONORS FOR A TRANSPLANT RECIPIENT | Final Rejection | CareDx, Inc. |
| 16666210 | HIGHLY SENSITIVE TRANSPLANT REJECTION SURVEILLANCE USING TARGETED DETECTION OF DONOR SPECIFIC CELL FREE DNA | Non-Final OA | The Medical College of Wisconsin, Inc |
| 15926977 | SYNTHETIC MULTIPLETS FOR MULTIPLETS DETERMINATION | Non-Final OA | Becton, Dickinson And Company |
| 17590659 | System, Method and Computer Simulation Environment For In Silico Trials in Pre-Diabetes and Type 2 Diabetes | Final Rejection | University of Virginia Patent Foundation |
| 15489658 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | Final Rejection | UNIVERSITY OF MARYLAND, BALTIMORE |
| 15028253 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | Final Rejection | UNIVERSITY OF MARYLAND, Baltimore |
| 17186816 | METHOD FOR VERIFYING CULTIVATION DEVICE PERFORMANCE | Non-Final OA | Hoffmann-La Roche Inc. |
| 18556328 | MACHINE LEARNING BASED HISTOPATHOLOGICAL RECURRENCE PREDICTION MODELS FOR HPV+ HEAD / NECK SQUAMOUS CELL CARCINOMA | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 16721619 | CELL-FREE DNA END CHARACTERISTICS | Final Rejection | GRAIL, Inc. |
| 17006124 | SYSTEMS AND METHODS FOR DETERMINING CONSENSUS BASE CALLS IN NUCLEIC ACID SEQUENCING | Non-Final OA | GRAIL, LLC |
| 17904561 | MICROORGANIC DETECTION SYSTEM WITH WORKLISTS | Non-Final OA | NEOGEN FOOD SAFETY US HOLCO CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy